173 related articles for article (PubMed ID: 16802400)
1. Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation.
Hong J; Jeppesen PB; Nordentoft I; Hermansen K
Diabetes Metab Res Rev; 2007 Mar; 23(3):202-10. PubMed ID: 16802400
[TBL] [Abstract][Full Text] [Related]
2. Stevioside counteracts the alpha-cell hypersecretion caused by long-term palmitate exposure.
Hong J; Chen L; Jeppesen PB; Nordentoft I; Hermansen K
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E416-22. PubMed ID: 16204336
[TBL] [Abstract][Full Text] [Related]
3. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
4. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
Vickers AE; Bentley P; Fisher RL
Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
[TBL] [Abstract][Full Text] [Related]
5. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
7. CPT1alpha over-expression increases long-chain fatty acid oxidation and reduces cell viability with incremental palmitic acid concentration in 293T cells.
Jambor de Sousa UL; Koss MD; Fillies M; Gahl A; Scheeder MR; Cardoso MC; Leonhardt H; Geary N; Langhans W; Leonhardt M
Biochem Biophys Res Commun; 2005 Dec; 338(2):757-61. PubMed ID: 16246309
[TBL] [Abstract][Full Text] [Related]
8. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
[TBL] [Abstract][Full Text] [Related]
9. Impact of glucagon-like peptide-1 (7-36) amide, isosteviol and 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside on leucine-mediated α-cell dysfunction.
Chen X; Hermansen K; Jeppesen PB
Diabetes Obes Metab; 2012 Nov; 14(11):1020-31. PubMed ID: 22747908
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
11. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
Schmitz FJ; Rösen P; Reinauer H
Horm Metab Res; 1995 Dec; 27(12):515-22. PubMed ID: 8750778
[TBL] [Abstract][Full Text] [Related]
12. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
13. A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
Caspary F; Elliott G; Navé BT; Verzaal P; Rohrbach M; Das PK; Nagelkerken L; Nieland JD
Br J Dermatol; 2005 Nov; 153(5):937-44. PubMed ID: 16225603
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P
J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680
[TBL] [Abstract][Full Text] [Related]
16. Effects of fatty acid regulation on visfatin gene expression in adipocytes.
Wen Y; Wang HW; Wu J; Lu HL; Hu XF; Cianflone K
Chin Med J (Engl); 2006 Oct; 119(20):1701-8. PubMed ID: 17097017
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-chain fatty acids on cytosolic triacylglycerol accumulation and lipid droplet formation in primary cultured bovine mammary epithelial cells.
Yonezawa T; Yonekura S; Kobayashi Y; Hagino A; Katoh K; Obara Y
J Dairy Sci; 2004 Aug; 87(8):2527-34. PubMed ID: 15328276
[TBL] [Abstract][Full Text] [Related]
18. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants inhibit fatty acid and glucose-mediated induction of neutral endopeptidase gene expression in human microvascular endothelial cells.
Muangman P; Tamura RN; Gibran NS
J Am Coll Surg; 2005 Feb; 200(2):208-15. PubMed ID: 15664096
[TBL] [Abstract][Full Text] [Related]
20. Regulation of leptin secretion from white adipocytes by free fatty acids.
Cammisotto PG; Gélinas Y; Deshaies Y; Bukowiecki LJ
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E521-6. PubMed ID: 12736159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
